| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Versant Venture Capital VII, L.P. | 10%+ Owner | $114M | Apr 4, 2022 | ||
| Alan Glicklich | Chief Medical Officer | $6.12M | Feb 10, 2022 | ||
| Ross Haghighat | Director | $5.21M | May 26, 2023 | ||
| Andrew Oxtoby | Chief Commercial Officer | $932K | Aug 11, 2023 | ||
| Robert Azelby | Director | $163K | Aug 11, 2023 | ||
| Eric Dobmeier | President, CEO, Director | Aug 11, 2023 | |||
| Jerel Davis | Director | Aug 11, 2023 | |||
| Eric Bjerkholt | Chief Financial Officer | Aug 11, 2023 | |||
| Dolca Thomas | Director | Aug 11, 2023 | |||
| Mahesh Krishnan | Director | Aug 11, 2023 | |||
| Tom Frohlich | Chief Operating Officer | Aug 11, 2023 | |||
| William M. Greenman | Director | Aug 11, 2023 | |||
| Michelle Renee Griffin | Director | Aug 11, 2023 | |||
| Srinivas Akkaraju | Director | Aug 11, 2023 | |||
| Andrew James King | Chief Scientific Officer | Aug 11, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|